Skye Biologics Holdings
PrivateLast Round
Private Placement
Mar 13, 2024
Total Funding Raised
$5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Skye Biologics Holdings is a biotechnology company that discovers and develops therapeutics from human biological material to treat degenerative diseases, damaged tissue, injuries, and trauma.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Skye Biologics Holdings Comparables
Compare Skye Biologics Holdings with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tides Medical | 89% | |
| Amnio Technology | 88% | |
| BioStem Technologies Inc | 87% |
Skye Biologics Holdings Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Private Placement | Mar 13, 2024 | ||||
| Private Placement | Jan 31, 2024 | ||||
| Private Placement | Aug 18, 2023 | ||||
| Convertible Debt | Aug 18, 2023 |
Skye Biologics Holdings Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Velan Capital | Private Placement |
| Perceptive Advisors | Private Placement |
| Schonfeld Strategic Advisors | Private Placement |
| Ally Bridge Group | Private Placement |
| Altium Capital | Private Placement |
| 5AM Ventures | Private Placement |
| Versant Ventures | Private Placement |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 38% MoM, reaching 2.9K.
- Jul 25, 2026
Monthly visitors grew 134% MoM, reaching 2.1K.
Skye Biologics Holdings Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Skye Biologics Holdings's valuation, stock price, and market status.
Is Skye Biologics Holdings a public or private company?
Skye Biologics Holdings is a private company.
What is the current stock price of Skye Biologics Holdings?
Skye Biologics Holdings is a private company with no public stock price. No recent secondary market data is available.
How much is Skye Biologics Holdings worth (valuation)?
Valuation information for Skye Biologics Holdings is not publicly available.
Can I buy Skye Biologics Holdings stock?
Skye Biologics Holdings shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Skye Biologics Holdings's last funding round?
Skye Biologics Holdings's most recent funding round was Private Placement on March 13, 2024.
Who are the main investors in Skye Biologics Holdings?
Key investors in Skye Biologics Holdings include 5AM Ventures.
Will Skye Biologics Holdings IPO soon?
No public IPO plans have been announced for Skye Biologics Holdings.
How can I track Skye Biologics Holdings secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Skye Biologics Holdings's secondary market activity and sign up for updates.